Dynasore (A1605): Technical Reference for Dynamin GTPase Inhibitor Workflows

What This Product Solves

Dynasore (SKU A1605) is a cell-permeable, non-competitive inhibitor designed to acutely and reversibly block the activity of dynamin family GTPases, including dynamin1, dynamin2, and Drp1 (Dynasore). These GTPases catalyze GTP hydrolysis, which is essential for vesicle membrane fission in endocytosis and intracellular trafficking. By inhibiting this process, Dynasore enables precise temporal dissection of dynamin-dependent endocytosis, vesicle trafficking, and related signaling pathways in cellular and neuronal models. This makes it an effective tool for endocytosis research, studies of synaptic vesicle cycling, and investigations into rapid signal transduction events. In particular, researchers can use Dynasore to experimentally control vesicle scission, facilitating the study of trafficking dynamics without long-term genetic manipulation.

For practical scenarios and decision-making in assay design, see the internal article 'Dynasore (SKU A1605): Precision Dynamin GTPase Inhibition...', which addresses real-world laboratory protocol optimization and troubleshooting.

Protocol Parameters

• Assay: Stock solution preparation
  Value: 16.12 mg/mL in DMSO
  Applicability: Required for all experimental setups
  Rationale: Dynasore is insoluble in water and ethanol but is readily soluble in DMSO at this concentration; warming to 37°C or using ultrasonic shaking improves dissolution.
  Source type: Product dossier
• Assay: Working concentration for dynamin inhibition
  Value: ~15 µM (IC50)
  Applicability: Use as an initial concentration for blocking dynamin-dependent endocytosis in cell-based models such as HeLa cells.
  Rationale: This is the IC50 value for dynamin GTPase inhibition, serving as a baseline for titration; actual working concentrations may require optimization.
  Source type: Product dossier
• Assay: Storage of stock solution
  Value: -20°C (DMSO stock)
  Applicability: All labs preparing aliquots for repeated use
  Rationale: Maintains compound stability; long-term storage of diluted solutions is not recommended due to potential loss of activity.
  Source type: Product dossier
• Assay: Vehicle (solvent) control
  Value: DMSO, ≤0.1% final concentration in assay
  Applicability: Required for all cell-based assays to control for solvent effects
  Rationale: Ensures observed effects are attributable to Dynasore, not DMSO. Source type: Workflow recommendation

Workflow Setup and QC Checklist

• Confirm complete solubilization of Dynasore in DMSO at the recommended stock concentration. Use gentle warming (37°C) or sonication to assist dissolution if precipitation is observed.
• Aliquot stock solutions to minimize freeze-thaw cycles. Store aliquots at -20°C and protect from light.
• Prepare fresh working dilutions immediately before use. Avoid prolonged (>24 hours) storage at working concentrations due to potential compound degradation.
• Validate inhibition by performing a functional assay (e.g., transferrin uptake in HeLa cells) with vehicle controls. Adjust Dynasore concentration based on observed inhibition and potential cytotoxicity.
• Check cell viability in parallel, particularly in sensitive or primary cells, as off-target or solvent effects may occur at higher concentrations.
• Document batch number, preparation date, and storage conditions for reproducibility and troubleshooting.

For additional protocol strategies and troubleshooting scenarios, see 'Dynasore (SKU A1605): Data-Driven Strategies for Endocytosis Research', which provides scenario-based evidence for cell viability and cytotoxicity assay workflows.

Common Failure Modes and Fixes

• Incomplete inhibition of endocytosis: Confirm Dynasore has fully dissolved and is used at or above its IC50. Titrate upwards in small increments if necessary, monitoring for cytotoxicity.
• Precipitation in buffer: Dynasore is insoluble in aqueous solutions; always dilute from DMSO stock directly into media or buffer immediately before use. Mix gently to avoid precipitation.
• Cytotoxicity or off-target effects: Reduce final DMSO concentration in assay to ≤0.1%, and verify effects in parallel vehicle controls. If unexpected toxicity persists, further decrease Dynasore concentration or shorten exposure time.
• Loss of activity after storage: Prepare fresh working dilutions and avoid long-term storage of diluted stocks. Aliquot and freeze DMSO stocks promptly after preparation.
• Batch-to-batch variability: Record and track batch numbers, and revalidate key functional assays with each new lot.

Scope and Limitations

• Dynasore is suitable for acute, reversible inhibition of dynamin GTPases in cell-based models and is widely used for investigating vesicle trafficking, synaptic vesicle endocytosis inhibition, and signal transduction pathway study.
• It is not suitable for applications requiring chronic or genetic inhibition, nor for in vivo use where aqueous solubility or extended compound stability is required.
• Its utility in cancer research is limited to in vitro mechanistic studies unless DMSO delivery and compound kinetics are thoroughly validated.
• Interpretation of results must consider off-target and solvent effects, particularly at higher concentrations or in sensitive cell types.
• Dynasore's inhibition is reversible and dose-dependent; recovery of endocytic activity can be used to confirm specificity, but prolonged exposure may confound results due to adaptation or toxicity.

Conclusion

Dynasore (A1605) from APExBIO is a practical, reliable tool for the reversible inhibition of dynamin-dependent endocytosis in cell and neuronal models. By following best practices in compound handling, solubilization, and assay control, researchers can achieve reproducible results in studies of vesicle trafficking and signal transduction. For full technical details and handling recommendations, refer to the Dynasore product page.